The Cure for What Ails Us Part II: Injecting Prevention for One and All

Chief Investment Officer Tony Roth speaks with Ofer Levy, MD, PhD, physician-scientist in pediatric infectious diseases, Director of the Precision Vaccines Program at Boston Children’s Hospital, and Professor at Harvard Medical School. Dr. Levy discusses the race to develop therapeutics, including plasma therapies, and when we can expect a viable vaccine. 305912 -- Wilmington Trust Corporation is a wholly owned subsidiary of M&T Bank Corporation.